+91 44 2496 8000 info@caplinpoint.net

Caplin Point forays into Bangladesh

Caplin Point laboratories expansion plan includes its foray into Bangladesh.Management at Caplin Point, Vivek Partheeban speaks to ET Now about theopportunities in some of the South East Asian countries, as far as the supply is concerned. Caplin Point laboratories deal with injectibles, which are used specifically in the hospitals. The foray into Bangladesh is more…

Read More »

Caplin Point Labs’ subsidiary inks distribution pact with Xellia Pharma for 5 injectables in US

Caplin Point Laboratories Chairman C C Paarthipan said the company has partnered with Xellia which has a long standing track record of commercial success in the US for injectable products. (Representational image: Reuters) Drug firm Caplin Point Laboratories on Tuesday said its subsidiary has entered into a distribution agreement with Xellia Pharmaceuticals for five injectable…

Read More »

BRIEF-Caplin Point Laboratories Unit Signs Pact With Xellia Pharmaceuticals

CAPLIN STERILES SIGNS PACT WITH XELLIAPHARMACEUTICALS CAPLIN STERILES TO LICENSE 5 INJECTABLE ANDAS TOXELLIA APPROVAL FOR 4 PRODUCTS EXPECTED WITHIN NEXT 12-18 MONTHS Source text for Eikon. https://www.reuters.com/article/brief-caplin-point-laboratories-ltd-capl/brief-caplin-point-laboratories-ltd-caplin-steriles-gets-usfda-approval-for-verapamil-hydrochloride-injection-usp-idUKFWN2BI1O1

Read More »

Caplin Point soars after final USFDA nod for Phenylephrine Hydrochloride injection

Caplin Point Laboratories jumped 6% to Rs 374 after the drug maker received the final approval from the US drug regulator for its Abbreviated New Drug Application (ANDA) Phenylephrine Hydrochloride injection. Phenylephrine Hydrochloride injection is indicated for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia. The drug had…

Read More »

Caplin Point jumps 6% on USFDA nod for local anesthesia

Caplin Point jumps 6% on USFDA nod for local anesthesia. This is a generic therapeutic equivalent version of NAROPINInjection, of Fresenius Kabi USA LLC. Shares of Caplin Point Laboratories jumped over 6 percent after the company said it has been granted final approval from the United States Food and Drug Administration (USFDA) for its RopivacaineHydrochloride…

Read More »

Caplin Point up 20% on USFDA approval for Verapamil Hydrochloride injection

2Y1Y6M1M5D1D Shares of Caplin Point Laboratories were locked inthe 20 per cent upper circuit at Rs 245 on the BSE on Thursday after the company’s arm Caplin Steriles received final approval from the US drug regulator for Verapamil Hydrochloride injection. Verapamil Hydrochloride is a calcium channel blocker used in the treatment of cardiac conditions such…

Read More »

Caplin Point likely to end FY20 with 10% revenue from the US

Caplin Point Laboratories received the US Food and Drug Administration. (USFDA) nod for its generic medicine for blood pressure. The product is of strategic importance to the company because of some of the other drugs that it has in similar therapeutic segments. “This is a product that we filed for approval last year. We have…

Read More »